📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

BRCA2 and RAD51 promote double-strand break formation and cell death in response to gemcitabine. (2014)

First Author: Jones RM

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/1535-7163.mct-13-0862

PubMed Identifier: 25053826

Publication URI: http://europepmc.org/abstract/MED/25053826

Type: Journal Article/Review

Volume: 13

Parent Publication: Molecular cancer therapeutics

Issue: 10

ISSN: 1535-7163